Latest & greatest articles for endometriosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on endometriosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on endometriosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for endometriosis

61. Treatment strategies for women with endometriosis and subfertility: a systematic review and network meta-analysis to compare the effectiveness of different intervention options, both medical and surgical in women with endometriosis for the treatment of su

Treatment strategies for women with endometriosis and subfertility: a systematic review and network meta-analysis to compare the effectiveness of different intervention options, both medical and surgical in women with endometriosis for the treatment of su Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content

2018 PROSPERO

62. The association between WNT4 gene polymorphisms and endometriosis risk in the Caucasian and Asian population: a meta-analysis

The association between WNT4 gene polymorphisms and endometriosis risk in the Caucasian and Asian population: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

63. Long term outcomes of post-operative hormonal suppression in patients with endometriosis: a systematic review and meta-analysis

Long term outcomes of post-operative hormonal suppression in patients with endometriosis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

64. The association between NAT2 gene polymorphisms and endometriosis risk in Caucasian and Asian population: a meta-analysis

The association between NAT2 gene polymorphisms and endometriosis risk in Caucasian and Asian population: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

65. Risk factors for depression in women diagnosed with endometriosis: a systematic review and meta-analysis

Risk factors for depression in women diagnosed with endometriosis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

66. A systematic review of psychological and mind-body interventions for reducing psychological distress and pain in women with endometriosis

A systematic review of psychological and mind-body interventions for reducing psychological distress and pain in women with endometriosis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

67. Comparison of the efficacy of GnRH agonist and levonorgestrel-releasing intrauterine system as a postoperative maintenance therapy of endometriosis: a meta-analysis

Comparison of the efficacy of GnRH agonist and levonorgestrel-releasing intrauterine system as a postoperative maintenance therapy of endometriosis: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g

2018 PROSPERO

68. Management of endometriosis

Management of endometriosis Haute Autorité de Santé - Management of endometriosis Fermer Choose language Accessibility Change contrast : Standards Reinforced icone Chercher icone plus Chercher My account My account Please fill in your email address to retrieve your email alerts subscriptions. Please fill in your email address to retrieve your newsletter subscriptions. You do not have a saved search Sélection No element in selection Services Services Déclarer un événement indésirable grave (...) Comment déclarer les EIGS Etre accrédité par la HAS Médecins exerçant une spécialité «à risques» Déposer une demande d'évaluation d'actes Modalités et procédures Organiser les soins, les parcours Coordination des soins, coopération entre professionnels Rechercher une recommandation, un guide, un médicament Rechercher une recommandation, un médicament, un guide Date : 13 December 2017 Mise à jour : 06/12/2018 Management of endometriosis Practice guidelines - Posted on Jan 17 2018 This clinical practice

2018 HAS Guidelines

69. Endometriosis factsheet

Endometriosis factsheet Endometriosis factsheet Endorsed by2 What is endometriosis? Do you see female patients? Do they have painful periods? Pain pre or post their periods? Painful sex? Do they suffer chronic pain, which may be intermittent or constant? Do they have pain when passing urine or with bowel movements? Is it painful to place a speculum for a smear test? Have you considered endometriosis? One in 10 women have endometriosis and it takes an average of seven years for most women to get (...) diagnosed. Endometriosis can often be confused with or misdiagnosed as IBS (irritable bowel syndrome). It is important that women receive a early diagnosis, or working diagnosis, of endometriosis even if hormonal treatments appear to be working, as women need to understand that they have a long term, chronic condition and the impact this might have on their future and their fertility. What is endometriosis? Endometriosis is defined as the presence of endometrial-like tissue outside the uterus, which

2018 Royal College of Nursing

70. Endometriosis: A Rare Cause of Large Bowel Obstruction Full Text available with Trip Pro

Endometriosis: A Rare Cause of Large Bowel Obstruction Large bowel obstruction can result in significant morbidity and mortality, especially in cases of acute complete obstruction. There are many possible causes, the most common in adults being colorectal cancer. Endometriosis is a benign disease, and the most affected extragenital location is the bowel, especially the rectosigmoid junction. However, transmural involvement and acute occlusion are very rare events. We report an exceptional case (...) of acute large bowel obstruction as the initial presentation of endometriosis. The differential diagnosis of colorectal carcinoma may be challenging, and this case emphasizes the need to consider intestinal endometriosis in females at a fertile age presenting with gastrointestinal symptoms and an intestinal mass causing complete large bowel obstruction.

2017 GE Portuguese journal of gastroenterology

71. Comparison between magnetic resonance and transvaginal ultrasound for deeply infiltrating endometriosis: a systematic review

Comparison between magnetic resonance and transvaginal ultrasound for deeply infiltrating endometriosis: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2017 PROSPERO

72. Endometriosis: diagnosis and management

Endometriosis: diagnosis and management Endometriosis: diagnosis and Endometriosis: diagnosis and management management NICE guideline Published: 6 September 2017 nice.org.uk/guidance/ng73 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When (...) with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Endometriosis: diagnosis and management (NG73) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 24Contents Contents Overview 4 Who is it for? 4 Recommendations 5 1.1

2017 National Institute for Health and Clinical Excellence - Clinical Guidelines

73. History of breast feeding and risk of incident endometriosis: prospective cohort study. Full Text available with Trip Pro

History of breast feeding and risk of incident endometriosis: prospective cohort study. Objective To investigate the association between lifetime breast feeding, exclusive breast feeding, postpartum amenorrhea, and incidence of endometriosis among parous women.Design Prospective cohort study.Setting Nurses' Health Study II, 1989-2011.Participants 72 394women who reported having one or more pregnancies that lasted at least six months, 3296 of whom had laparoscopically confirmed endometriosis (...) . For each pregnancy, women reported duration of total breast feeding, exclusive breast feeding, and postpartum amenorrhea. Main outcome measures Incident self reported laparoscopically confirmed endometriosis (96% concordance with medical record) in parous women. Multivariable Cox proportional hazard models were used to calculate hazard ratios and 95% confidence intervals for diagnosis of endometriosis.Results Duration of total and exclusive breast feeding was significantly associated with decreased

2017 BMJ

74. Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus? Assessment according to §137h Social Code Book V

Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus? Assessment according to §137h Social Code Book V 1 Translation of the executive summary of the assessment according to §137h Social Code Book (SGB) V Sonografiegesteuerte hochfokussierte Ultraschalltherapie bei der Endometriose des Uterus (Version 1.0; Status: 30 January 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text (...) is absolutely authoritative and legally binding. Executive Summary IQWiG Reports – Commission No. H16-02A Ultrasound-guided high- intensity focused ultrasound therapy for uterine endometriosis 1 Executive summary of assessment H16-02A according to §137h SGB V Version 1.0 USgHIFU for uterine endometriosis 30 January 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Ultrasound-guided high-intensity

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

75. Progesterone receptor modulators for endometriosis. Full Text available with Trip Pro

Progesterone receptor modulators for endometriosis. Endometriosis is defined as the presence of endometrial tissue (glands and stroma) outside the uterine cavity. This condition is oestrogen-dependent and thus is seen primarily during the reproductive years. Owing to their antiproliferative effects in the endometrium, progesterone receptor modulators (PRMs) have been advocated for treatment of endometriosis.To assess the effectiveness and safety of PRMs primarily in terms of pain relief (...) or bleeding (OR 22.92, 95% CI 2.64 to 198.66; one RCT, n = 49; low-quality evidence).Evidence was insufficient to show differences in effectiveness or safety between different doses of gestrinone, if present. Asoprisnil versus placebo One study (n = 130) made this comparison but did not report data suitable for analysis. Ulipristal versus leuprolide acetate One study (n = 38) made this comparison but did not report data suitable for analysis.Among women with endometriosis, moderate-quality evidence shows

2017 Cochrane

76. [Endometriosis and miscarriage: Systematic review]. (Abstract)

[Endometriosis and miscarriage: Systematic review]. In spontaneous pregnancies, endometriosis appears to be a risk factor of miscarriage. The aim of this study is to evaluate the association between endometriosis and miscarriage in spontaneous pregnancy.We searched the Cochrane Library, Medline of eligible studies from inception to December 2016, without any restriction. We selected studies that compared endometriosis-affected pregnant women to disease-free pregnant women. To ensure the quality (...) of the methodology, the PRISMA criteria have been met at all stages of the development of this meta-analysis. The primary adverse pregnancy outcomes studied was miscarriage. Three reviewers independently extracted the studies' characteristics and outcome data.Of 225 identified abstracts, 4 primary studies met our inclusion criteria by comparing spontaneous pregnant patients with endometriosis to disease-free women. Miscarriage rate was higher in the endometriosis group (OR 1.77 [CI 95% 1.13-2.78]).In spontaneous

2017 Gynecologie, obstetrique, fertilite & senologie

77. Micronized palmitoylethanolamide/trans-polydatin treatment of endometriosis-related pain: a meta-analysis. (Abstract)

Micronized palmitoylethanolamide/trans-polydatin treatment of endometriosis-related pain: a meta-analysis. To demonstrate clinical effectiveness of micronized palmitoylethanolamide-trans-polydatin combination in reducing endometriotic chronic pelvic pain. Other endometriotic-pains were also assessed.Systematic reviews of PubMed, SCIELO, Scopus, and AJOL. Randomized trials and observational studies reporting a visual analogue scale for pain or similar in endometriotic patients were reviewed

2017 Annali dell'Istituto superiore di sanita

78. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. Full Text available with Trip Pro

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. Endometriosis is a chronic, estrogen-dependent condition that causes dysmenorrhea and pelvic pain. Elagolix, an oral, nonpeptide, gonadotropin-releasing hormone (GnRH) antagonist, produced partial to nearly full estrogen suppression in previous studies.We performed two similar, double-blind, randomized, 6-month phase 3 trials (Elaris Endometriosis I and II [EM-I and EM-II]) to evaluate the effects of two doses (...) of elagolix - 150 mg once daily (lower-dose group) and 200 mg twice daily (higher-dose group) - as compared with placebo in women with surgically diagnosed endometriosis and moderate or severe endometriosis-associated pain. The two primary efficacy end points were the proportion of women who had a clinical response with respect to dysmenorrhea and the proportion who had a clinical response with respect to nonmenstrual pelvic pain at 3 months. Each of these end points was measured as a clinically

2017 NEJM Controlled trial quality: predicted high

79. Cancer-Associated Mutations in Endometriosis without Cancer. Full Text available with Trip Pro

Cancer-Associated Mutations in Endometriosis without Cancer. Endometriosis, defined as the presence of ectopic endometrial stroma and epithelium, affects approximately 10% of reproductive-age women and can cause pelvic pain and infertility. Endometriotic lesions are considered to be benign inflammatory lesions but have cancerlike features such as local invasion and resistance to apoptosis.We analyzed deeply infiltrating endometriotic lesions from 27 patients by means of exomewide sequencing (24 (...) carried identical KRAS c.35G→A mutations in three distinct lesions.We found that lesions in deep infiltrating endometriosis, which are associated with virtually no risk of malignant transformation, harbor somatic cancer driver mutations. Ten of 39 deep infiltrating lesions (26%) carried driver mutations; all the tested somatic mutations appeared to be confined to the epithelial compartment of endometriotic lesions.

2017 NEJM

80. Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to õ137h Social Code Book V

Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to õ137h Social Code Book V Sonografiegesteuerte hochfokussierte Ultraschalltherapie bei der Endometriose des Uterus: Bewertungen gemäß § 137h SGB V; Auftrag: H16-02A [Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to §137h Social Code Book V] Sonografiegesteuerte hochfokussierte Ultraschalltherapie bei der Endometriose des Uterus (...) : Bewertungen gemäß § 137h SGB V; Auftrag: H16-02A [Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to §137h Social Code Book V] Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im

2017 Health Technology Assessment (HTA) Database.